RxDoctor Payments Data

Jose Bazan, DO

Infectious Disease · Columbus, OHNPI 1326168832

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $6,590 of the $9,384 with a category attached, or 70.2%. Gilead accounts for 89.3% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2024 at $6,354 and has fallen 68.1% since, to $2,030 in 2025. Among infectious disease clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,384in general payments, 2019–2025

Across 13 payments — averaging $721.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$8K
  • Siemens Medical Solutions USA, Inc.$1K
$137,347in research payments, 2019–2025

Across 38 payments — averaging $3614.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Gilead$73K
  • Viiv Healthcare Company$52K
  • GE HealthCare$12K

What the payments were for

  • Consulting fees$6,59070%
  • Speaking & faculty fees$1,00011%
  • Travel & lodging$1,30614%
  • Food & beverage$4885%

General payments by program year

22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Gilead12$8,384
Siemens Medical Solutions USA, Inc.1$1,000

How this compares

$9,384 in reported general payments places this provider in the 90th percentile of 308 infectious disease providers in Ohio.

See all infectious disease providers in Ohio

Medicare billing

Part B allowed, 2024
$12,564
Medicare patients
78
Services billed
101

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other infectious disease in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →